Table 2.
Characteristics of patients with hepatolithiasis.
| LLHH (n = 21) | CLLH (n = 32) | p | |
|---|---|---|---|
| Gender (M/F) | 8/5 | 12/4 | 0.989 |
| Age (years) | 52 ± 13 | 50 ± 13 | 0.916 |
| BMI (kg/m2) | 22.6 ± 3.2 | 23.2 ± 3.7 | 0.374 |
| With CBDE | 15 | 21 | 0.155 |
| Operative time (min) | 180 ± 66 | 233 ± 98 | 0.035 |
| Blood loss (mL) | 221 ± 108 | 297 ± 121 | 0.023 |
| Transfusion | 3 | 5 | 0.841 |
| Hospital stay (days) | 9.6 ± 3.2 | 10.6 ± 2.8 | 0.276 |
| Hospital expenses (WanRMB) | 5.5 ± 1.2 | 5.9 ± 1.1 | 0.195 |
| Bile leakage | 3 | 10 | 0.164 |
| Clavien–Dindo grade | 15 | 28 | 0.147 |
| I–II | 12 | 21 | 0.537 |
| III–IV | 3 | 7 | 0.494 |
| Postoperative laboratory data | |||
| WBC (109/L) | 12.5 ± 3.5 | 13.5 ± 3.7 | 0.335 |
| AST (U/L) | 219 (98–258) | 238 (122–331) | 0.403 |
| ALT (U/L) | 218 (140–250) | 242 (105–333) | 0.501 |
LLHH, laparoscopic left hemihepatectomy of the head; CLLH, conventional laparoscopic left hemihepatectomy; CBDE, common bile duct exploration; WBC, blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; WanRMB, ten thousand renminbi.
Bold font indicates statistical significance.